These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 29142155)

  • 1. Modulation of High-Density Lipoprotein Function via Cardiac Rehabilitation.
    Satomi-Kobayashi S; Ishida T
    J Atheroscler Thromb; 2018 Feb; 25(2):128-130. PubMed ID: 29142155
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of Cardiac Rehabilitation on High-Density Lipoprotein-mediated Cholesterol Efflux Capacity and Paraoxonase-1 Activity in Patients with Acute Coronary Syndrome.
    Furuyama F; Koba S; Yokota Y; Tsunoda F; Shoji M; Kobayashi Y
    J Atheroscler Thromb; 2018 Feb; 25(2):153-169. PubMed ID: 28855433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of exercise-based cardiac rehabilitation on non-culprit mild coronary plaques in the culprit coronary artery of patients with acute coronary syndrome.
    Kurose S; Iwasaka J; Tsutsumi H; Yamanaka Y; Shinno H; Fukushima Y; Higurashi K; Imai M; Masuda I; Takeda S; Kawai C; Kimura Y
    Heart Vessels; 2016 Jun; 31(6):846-54. PubMed ID: 25896129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.
    Haraguchi Y; Toh R; Hasokawa M; Nakajima H; Honjo T; Otsui K; Mori K; Miyamoto-Sasaki M; Shinohara M; Nishimura K; Ishida T; Hirata K
    Atherosclerosis; 2014 Jun; 234(2):288-94. PubMed ID: 24704632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the differences of body mass index and waist circumference in the follow-up assessment of patients to cardiac rehabilitation with acute coronary syndrome.
    Zhao H; Ma J; Zhou Q; Chen W; Zhu W; Cai Z; Lei H; Deng Y; Xu L; Qiu J
    Australas Phys Eng Sci Med; 2016 Dec; 39(4):1007-1027. PubMed ID: 27832460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation impairs eNOS activation by HDL in patients with acute coronary syndrome.
    Gomaraschi M; Ossoli A; Favari E; Adorni MP; Sinagra G; Cattin L; Veglia F; Bernini F; Franceschini G; Calabresi L
    Cardiovasc Res; 2013 Oct; 100(1):36-43. PubMed ID: 23812298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes.
    Androulakis E; Zacharia E; Papageorgiou N; Lioudaki E; Bertsias D; Charakida M; Siasos G; Tousoulis D
    Curr Cardiol Rev; 2017; 13(3):168-182. PubMed ID: 28190386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiatherogenic effect of high density lipoprotein].
    Turczyn B; Skoczyńska A
    Postepy Hig Med Dosw; 2002; 56(4):499-520. PubMed ID: 12418415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of HDL functionality and PON1 activities in acute coronary syndrome patients.
    Bounafaa A; Berrougui H; Ikhlef S; Essamadi A; Nasser B; Bennis A; Yamoul N; Ghalim N; Khalil A
    Clin Biochem; 2014 Dec; 47(18):318-25. PubMed ID: 25218815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-density lipoprotein mediated cellular cholesterol efflux in acute coronary syndromes.
    Hafiane A; Jabor B; Ruel I; Ling J; Genest J
    Am J Cardiol; 2014 Jan; 113(2):249-55. PubMed ID: 24210679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory investigation of dysfunctional HDL.
    Guo ZG; Li C; Zhong JK; Tu Y; Xie D
    Chem Phys Lipids; 2012 Jan; 165(1):32-7. PubMed ID: 22064068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between HDL particles size and myeloperoxidase/ paraoxonase-1 (MPO/PON1) ratio in patients with acute coronary syndrome.
    Emami Razavi A; Basati G; Varshosaz J; Abdi S
    Acta Med Iran; 2013 Jul; 51(6):365-71. PubMed ID: 23852840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
    Gugliucci A
    Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target.
    Lüscher TF; Landmesser U; von Eckardstein A; Fogelman AM
    Circ Res; 2014 Jan; 114(1):171-82. PubMed ID: 24385510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial).
    Ballantyne CM; Pitt B; Loscalzo J; Cain VA; Raichlen JS
    Am J Cardiol; 2013 Feb; 111(4):506-9. PubMed ID: 23237107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial.
    Ray KK; Ditmarsch M; Kallend D; Niesor EJ; Suchankova G; Upmanyu R; Anzures-Cabrera J; Lehnert V; Pauly-Evers M; Holme I; Štásek J; van Hessen MW; Jones P;
    Eur Heart J; 2014 Jul; 35(27):1792-800. PubMed ID: 24639426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosuvastatin-induced high-density lipoprotein changes in patients who underwent percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome.
    Yun KH; Shin SN; Ko JS; Rhee SJ; Kim NH; Oh SK; Jeong JW
    J Cardiol; 2012 Nov; 60(5):383-8. PubMed ID: 22884684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.
    Kempen HJ; van Gent CM; Buytenhek R; Buis B
    J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endotoxin levels are associated with high-density lipoprotein, triglycerides, and troponin in patients with acute coronary syndrome and angina: possible contributions from periodontal sources.
    Goteiner D; Craig RG; Ashmen R; Janal MN; Eskin B; Lehrman N
    J Periodontol; 2008 Dec; 79(12):2331-9. PubMed ID: 19053924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.